306 related articles for article (PubMed ID: 38570827)
1. B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice.
Hayakawa K; Zhou Y; Shinton SA
Immun Ageing; 2024 Apr; 21(1):22. PubMed ID: 38570827
[TBL] [Abstract][Full Text] [Related]
2. Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression.
Hayakawa K; Formica AM; Brill-Dashoff J; Shinton SA; Ichikawa D; Zhou Y; Morse HC; Hardy RR
J Exp Med; 2016 Dec; 213(13):3007-3024. PubMed ID: 27899442
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
[TBL] [Abstract][Full Text] [Related]
4. CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation.
Efanov A; Zanesi N; Nazaryan N; Santanam U; Palamarchuk A; Croce CM; Pekarsky Y
Leukemia; 2010 May; 24(5):970-5. PubMed ID: 20357824
[TBL] [Abstract][Full Text] [Related]
5. Accelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1.
Nganga VK; Palmer VL; Naushad H; Kassmeier MD; Anderson DK; Perry GA; Schabla NM; Swanson PC
Blood; 2013 May; 121(19):3855-66, S1-16. PubMed ID: 23502221
[TBL] [Abstract][Full Text] [Related]
6. ROR1 can interact with TCL1 and enhance leukemogenesis in Eμ-TCL1 transgenic mice.
Widhopf GF; Cui B; Ghia EM; Chen L; Messer K; Shen Z; Briggs SP; Croce CM; Kipps TJ
Proc Natl Acad Sci U S A; 2014 Jan; 111(2):793-8. PubMed ID: 24379361
[TBL] [Abstract][Full Text] [Related]
7. Early Generated B-1-Derived B Cells Have the Capacity To Progress To Become Mantle Cell Lymphoma-like Neoplasia in Aged Mice.
Hayakawa K; Formica AM; Nakao Y; Ichikawa D; Shinton SA; Brill-Dashoff J; Smith MR; Morse HC; Hardy RR
J Immunol; 2018 Jul; 201(2):804-813. PubMed ID: 29898964
[TBL] [Abstract][Full Text] [Related]
8. High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia.
Herling M; Patel KA; Weit N; Lilienthal N; Hallek M; Keating MJ; Jones D
Blood; 2009 Nov; 114(21):4675-86. PubMed ID: 19770358
[TBL] [Abstract][Full Text] [Related]
9. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.
Bichi R; Shinton SA; Martin ES; Koval A; Calin GA; Cesari R; Russo G; Hardy RR; Croce CM
Proc Natl Acad Sci U S A; 2002 May; 99(10):6955-60. PubMed ID: 12011454
[TBL] [Abstract][Full Text] [Related]
10. Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
Ghergus D; Martin M; Knapp AM; Delmotte F; Joublin-Delavat A; Jung S; Schickel JN; Mendel I; Dupuis A; Drénou B; Ghesquières H; Salles G; Baseggio L; Herbrecht R; Korganow AS; Vallat L; Soulas-Sprauel P; Meffre E; Martin T
Am J Hematol; 2024 Jan; 99(1):48-56. PubMed ID: 37853951
[TBL] [Abstract][Full Text] [Related]
11. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
[TBL] [Abstract][Full Text] [Related]
12. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.
Yan XJ; Albesiano E; Zanesi N; Yancopoulos S; Sawyer A; Romano E; Petlickovski A; Efremov DG; Croce CM; Chiorazzi N
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11713-8. PubMed ID: 16864779
[TBL] [Abstract][Full Text] [Related]
13. Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia.
Sanchez-Aguilera A; Rattmann I; Drew DZ; Müller LU; Summey V; Lucas DM; Byrd JC; Croce CM; Gu Y; Cancelas JA; Johnston P; Moritz T; Williams DA
Leukemia; 2010 Jan; 24(1):97-104. PubMed ID: 19847197
[TBL] [Abstract][Full Text] [Related]
14. T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B-cells due to ZAP70 overexpression in patient T-cells.
Rizzo D; Bouvier G; Youlyouz-Marfak I; Guerin E; Trimoreau F; Bordessoule D; Jaccard A; Gachard N; Feuillard J
Cytometry B Clin Cytom; 2013 Mar; 84(2):125-32. PubMed ID: 23225571
[TBL] [Abstract][Full Text] [Related]
15. Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL).
Palamarchuk A; Yan PS; Zanesi N; Wang L; Rodrigues B; Murphy M; Balatti V; Bottoni A; Nazaryan N; Alder H; Rassenti L; Kipps TJ; Freitas M; Croce CM; Pekarsky Y
Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2555-60. PubMed ID: 22308499
[TBL] [Abstract][Full Text] [Related]
16. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.
Zanesi N; Aqeilan R; Drusco A; Kaou M; Sevignani C; Costinean S; Bortesi L; La Rocca G; Koldovsky P; Volinia S; Mancini R; Calin G; Scott CP; Pekarsky Y; Croce CM
Cancer Res; 2006 Jan; 66(2):915-20. PubMed ID: 16424025
[TBL] [Abstract][Full Text] [Related]
17. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state.
Herling M; Patel KA; Khalili J; Schlette E; Kobayashi R; Medeiros LJ; Jones D
Leukemia; 2006 Feb; 20(2):280-5. PubMed ID: 16341048
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.
DiLillo DJ; Weinberg JB; Yoshizaki A; Horikawa M; Bryant JM; Iwata Y; Matsushita T; Matta KM; Chen Y; Venturi GM; Russo G; Gockerman JP; Moore JO; Diehl LF; Volkheimer AD; Friedman DR; Lanasa MC; Hall RP; Tedder TF
Leukemia; 2013 Jan; 27(1):170-82. PubMed ID: 22713648
[TBL] [Abstract][Full Text] [Related]
19. Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cells.
Liu J; Chen G; Feng L; Zhang W; Pelicano H; Wang F; Ogasawara MA; Lu W; Amin HM; Croce CM; Keating MJ; Huang P
Leukemia; 2014 Jan; 28(1):118-28. PubMed ID: 23608884
[TBL] [Abstract][Full Text] [Related]
20. Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion.
Palmer VL; Nganga VK; Rothermund ME; Perry GA; Swanson PC
BMC Immunol; 2015 Nov; 16():66. PubMed ID: 26537916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
